Mitochondrial regulation in human pluripotent stem cells during reprogramming and β cell differentiation.

Diabetes Mellitus beta cells (β Cells) induced pluripotent stem (iPS) cells islet transplantation stem cells

Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 07 06 2023
accepted: 06 10 2023
medline: 7 11 2023
pubmed: 6 11 2023
entrez: 6 11 2023
Statut: epublish

Résumé

Mitochondria are the powerhouse of the cell and dynamically control fundamental biological processes including cell reprogramming, pluripotency, and lineage specification. Although remarkable progress in induced pluripotent stem cell (iPSC)-derived cell therapies has been made, very little is known about the role of mitochondria and the mechanisms involved in somatic cell reprogramming into iPSC and directed reprogramming of iPSCs in terminally differentiated cells. Reprogramming requires changes in cellular characteristics, genomic and epigenetic regulation, as well as major mitochondrial metabolic changes to sustain iPSC self-renewal, pluripotency, and proliferation. Differentiation of autologous iPSC into terminally differentiated β-like cells requires further metabolic adaptation. Many studies have characterized these alterations in signaling pathways required for the generation and differentiation of iPSC; however, very little is known regarding the metabolic shifts that govern pluripotency transition to tissue-specific lineage differentiation. Understanding such metabolic transitions and how to modulate them is essential for the optimization of differentiation processes to ensure safe iPSC-derived cell therapies. In this review, we summarize the current understanding of mitochondrial metabolism during somatic cell reprogramming to iPSCs and the metabolic shift that occurs during directed differentiation into pancreatic β-like cells.

Identifiants

pubmed: 37929027
doi: 10.3389/fendo.2023.1236472
pmc: PMC10623316
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1236472

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

Copyright © 2023 Jasra, Cuesta-Gomez, Verhoeff, Marfil-Garza, Dadheech and Shapiro.

Déclaration de conflit d'intérêts

AS serves as a consultant to ViaCyte Inc., Hemostemix Inc., Protokinetix Inc. and Pelican Therapeutics Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

EMBO J. 2011 Nov 15;30(24):4860-73
pubmed: 22085932
Anal Biochem. 2018 Jul 1;552:50-59
pubmed: 28711444
Antioxid Redox Signal. 2007 Mar;9(3):293-9
pubmed: 17184172
Biomedicines. 2022 Jun 09;10(6):
pubmed: 35740381
Cell Mol Life Sci. 2009 Jan;66(1):27-42
pubmed: 18726182
Biochem J. 2015 Mar 1;466(2):203-18
pubmed: 25697093
Cell Stem Cell. 2013 Jan 3;12(1):127-37
pubmed: 23168164
Stem Cells. 2016 Jun;34(6):1427-36
pubmed: 26889666
J Biol Chem. 2008 Oct 17;283(42):28506-12
pubmed: 18713735
Cell Metab. 2011 Aug 3;14(2):264-71
pubmed: 21803296
Nat Clin Pract Cardiovasc Med. 2007 Feb;4 Suppl 1:S60-7
pubmed: 17230217
Front Cell Dev Biol. 2020 Feb 28;8:87
pubmed: 32181250
Cell Stem Cell. 2014 May 1;14(5):592-605
pubmed: 24656769
J Am Chem Soc. 2014 Jul 16;136(28):9798-801
pubmed: 24992689
Antioxid Redox Signal. 2014 Apr 20;20(12):1881-90
pubmed: 23066813
Nat Cell Biol. 2015 Nov;17(11):1379-87
pubmed: 26502054
Curr Opin Neurobiol. 2021 Aug;69:231-240
pubmed: 34171617
Trends Mol Med. 2020 Feb;26(2):185-200
pubmed: 31679988
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
Cell Metab. 2015 Mar 3;21(3):392-402
pubmed: 25738455
Stem Cells. 2010 Apr;28(4):661-73
pubmed: 20073085
J Biol Chem. 2021 Dec;297(6):101410
pubmed: 34785214
Stem Cell Res. 2018 Mar;27:121-130
pubmed: 29414602
Stem Cells. 2019 Aug;37(8):1042-1056
pubmed: 31042329
Nat Commun. 2020 Jan 3;11(1):102
pubmed: 31900386
Cell Death Differ. 2009 Jul;16(7):939-46
pubmed: 19229244
Eur J Endocrinol. 2011 Oct;165(4):589-95
pubmed: 21775499
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
Cell Prolif. 2021 May;54(5):e13034
pubmed: 33931895
Nat Chem Biol. 2010 Jun;6(6):411-7
pubmed: 20436487
Arch Toxicol. 2018 Feb;92(2):693-704
pubmed: 28956099
Nat Biotechnol. 2014 Nov;32(11):1121-33
pubmed: 25211370
Development. 2014 Nov;141(22):4206-18
pubmed: 25371358
J Cell Sci. 2012 Feb 15;125(Pt 4):795-9
pubmed: 22448035
Metab Eng. 2019 May;53:35-47
pubmed: 30779965
PLoS One. 2014 Mar 19;9(3):e85039
pubmed: 24647085
Cell Stem Cell. 2013 Feb 7;12(2):167-79
pubmed: 23318055
Cell Rep. 2017 Apr 4;19(1):20-35
pubmed: 28380358
Protein Sci. 2010 Nov;19(11):2031-44
pubmed: 20857498
Nature. 2015 Apr 16;520(7547):363-7
pubmed: 25855294
J Cell Biol. 2009 Sep 21;186(6):805-16
pubmed: 19752021
Front Neurosci. 2015 Feb 09;9:23
pubmed: 25709564
Cell Death Differ. 2015 Dec;22(12):1957-69
pubmed: 25882047
Cell Rep. 2012 Dec 27;2(6):1579-92
pubmed: 23260666
In Vitro Cell Dev Biol Anim. 2020 May;56(5):378-385
pubmed: 32514718
Cell. 2015 Jul 16;162(2):452-453
pubmed: 28843285
Cells. 2021 Jan 30;10(2):
pubmed: 33573247
Cell Death Discov. 2022 Feb 17;8(1):69
pubmed: 35177589
Int J Mol Sci. 2021 May 20;22(10):
pubmed: 34065350
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
Biotechnol Bioeng. 2008 Oct 1;101(2):241-54
pubmed: 18727033
Stem Cells. 2014 Feb;32(2):364-76
pubmed: 24123565
PLoS One. 2011;6(6):e20914
pubmed: 21698063
Physiol Rev. 2014 Jul;94(3):909-50
pubmed: 24987008
Stem Cells Dev. 2015 Sep 1;24(17):1957-71
pubmed: 26134242
Diabetes. 2002 Oct;51(10):2989-96
pubmed: 12351438
Diabetes. 2015 Oct;64(10):3475-84
pubmed: 26085571
EMBO J. 2017 May 15;36(10):1330-1347
pubmed: 28377463
Cell Stem Cell. 2013 Sep 5;13(3):270-83
pubmed: 24012368
J Biol Chem. 1994 Feb 18;269(7):4895-902
pubmed: 8106462
PLoS One. 2011;6(11):e27352
pubmed: 22110631
J Biol Chem. 2009 Sep 25;284(39):26578-90
pubmed: 19635791
Mol Cell. 2016 Jun 2;62(5):695-711
pubmed: 27259202
Stem Cell Reports. 2019 Feb 12;12(2):351-365
pubmed: 30661993
Cell Stem Cell. 2010 Dec 3;7(6):651-5
pubmed: 21112560
Front Neurosci. 2018 Dec 03;12:865
pubmed: 30559639
Int J Mol Sci. 2018 Dec 05;19(12):
pubmed: 30563106
Stem Cell Reports. 2017 Mar 14;8(3):787-801
pubmed: 28262547
Nat Biotechnol. 2022 Jul;40(7):1042-1055
pubmed: 35241836
Nucleic Acids Res. 2003 Sep 1;31(17):5039-47
pubmed: 12930954
Heliyon. 2020 Apr 01;6(4):e03651
pubmed: 32258510
J Cell Sci. 2007 Nov 15;120(Pt 22):4025-34
pubmed: 17971411
Biochim Biophys Acta. 2012 Sep-Oct;1819(9-10):998-1007
pubmed: 22023881
Mol Cell Endocrinol. 2013 Oct 15;379(1-2):12-8
pubmed: 23792187
Cell Death Differ. 2010 Nov;17(11):1684-96
pubmed: 20467441
Cell Rep. 2015 Aug 18;12(7):1080-8
pubmed: 26257174
Nat Cell Biol. 2009 Aug;11(8):958-66
pubmed: 19578372
J Biol Chem. 2008 Nov 28;283(48):33347-56
pubmed: 18832378
J Gerontol A Biol Sci Med Sci. 2021 Sep 13;76(10):1707-1713
pubmed: 34003967
Commun Biol. 2021 May 19;4(1):594
pubmed: 34012065
Ann Med. 2005;37(3):213-21
pubmed: 16019720
Stem Cell Reports. 2014 Jan 02;2(1):44-51
pubmed: 24511469
Dev Cell. 2013 Apr 15;25(1):81-92
pubmed: 23597483
Inflamm Regen. 2020 May 12;40:8
pubmed: 32426078
Tissue Eng Part C Methods. 2018 Oct;24(10):605-615
pubmed: 30234460
PLoS One. 2010 Nov 23;5(11):e14095
pubmed: 21124794
Transpl Int. 2022 Aug 24;35:10575
pubmed: 36090777
Cell Rep. 2020 May 12;31(6):107623
pubmed: 32402282
Biochim Biophys Acta. 2014 Dec;1846(2):285-96
pubmed: 25064846
Clin Cancer Res. 2012 Nov 15;18(22):6089-95
pubmed: 23019305
JCI Insight. 2021 Mar 8;6(5):
pubmed: 33529174
Antioxid Redox Signal. 2021 Feb 1;34(4):335-349
pubmed: 32567336
EMBO J. 2012 May 2;31(9):2103-16
pubmed: 22446391
Diabetologia. 2001 Dec;44(12):2187-91
pubmed: 11793020
Cell Stem Cell. 2013 Nov 7;13(5):617-25
pubmed: 24209762
Int J Mol Sci. 2019 May 07;20(9):
pubmed: 31067778
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Cell. 2015 Jul 16;162(2):412-424
pubmed: 26186193
Diabetologia. 2003 Oct;46(10):1297-312
pubmed: 13680127
Cell Rep. 2020 Aug 25;32(8):108067
pubmed: 32846125
Cell Metab. 2007 Apr;5(4):253-64
pubmed: 17403370
Int J Dev Biol. 2010;54(11-12):1729-41
pubmed: 21305470
J Biol. 2007 Dec 21;6(4):10
pubmed: 18154684
Int J Mol Sci. 2021 Jan 25;22(3):
pubmed: 33503959
Aging (Albany NY). 2012 Jun;4(6):393-401
pubmed: 22713507
Sci Rep. 2018 Aug 20;8(1):12427
pubmed: 30127448
Gerontology. 2014;60(2):174-82
pubmed: 24281332
Nature. 2023 Aug;620(7975):863-872
pubmed: 37587336
Aging Cell. 2011 Oct;10(5):908-11
pubmed: 21615676
Stem Cells. 2015 Sep;33(9):2699-711
pubmed: 26059508
Cell Rep. 2023 Aug 29;42(8):112970
pubmed: 37556323
Stem Cells. 2011 Mar;29(3):486-95
pubmed: 21425411
Dev Biol. 1977 Mar;56(1):219-25
pubmed: 838132
Stem Cell Reports. 2018 Dec 11;11(6):1479-1492
pubmed: 30472011
Stem Cells. 2011 Sep;29(9):1338-48
pubmed: 21732474
Diabetes. 2009 Oct;58(10):2303-15
pubmed: 19581419
J Biol Chem. 2019 Apr 5;294(14):5420-5429
pubmed: 29463682
Stem Cell Res Ther. 2023 Jun 6;14(1):154
pubmed: 37280707
Int J Stem Cells. 2011 Jun;4(1):1-8
pubmed: 24298328
Cell. 2012 Jan 20;148(1-2):259-72
pubmed: 22225612
Nat Genet. 2000 Nov;26(3):336-40
pubmed: 11062475
Cell Res. 2012 Jan;22(1):168-77
pubmed: 22064701
Nat Cell Biol. 2019 Feb;21(2):263-274
pubmed: 30710150
Int J Mol Sci. 2021 Jun 23;22(13):
pubmed: 34201756
Cell Cycle. 2011 Nov 1;10(21):3658-77
pubmed: 22052357
Nat Cell Biol. 2015 Jun;17(6):715-25
pubmed: 25985393
Stem Cells. 2010 Apr;28(4):721-33
pubmed: 20201066

Auteurs

Ila Tewari Jasra (IT)

Clinical Islet Transplant Program, Department of Surgery, Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.

Nerea Cuesta-Gomez (N)

Clinical Islet Transplant Program, Department of Surgery, Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.

Kevin Verhoeff (K)

Clinical Islet Transplant Program, Department of Surgery, Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.

Braulio A Marfil-Garza (BA)

Clinical Islet Transplant Program, Department of Surgery, Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.
Tecnologico de Monterrey, The Institute for Obesity Research, Monterrey, Nuevo Leon, Mexico.

Nidheesh Dadheech (N)

Clinical Islet Transplant Program, Department of Surgery, Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.

A M James Shapiro (AMJ)

Clinical Islet Transplant Program, Department of Surgery, Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH